Molecularix Biolabs owl emblemMolecularixBiolabs
Research Library
PRECLINICAL

Follistatin-344

Also known as: FST-344

Growth Factor ResearchMuscle Biology Research
ClassificationRecombinant isoform of follistatin, an endogenous activin/myostatin-binding glycoprotein.
TargetsMyostatin/activin binding; TGF-β superfamily signaling models

Molecular Overview

Follistatin-344 is a follistatin isoform studied in preclinical models for its ability to bind and neutralize activin and myostatin.

Mechanistic Background

Sequesters TGF-β-superfamily ligands (activin A, myostatin) in experimental systems.

What Researchers Study

Gene-therapy and protein-based preclinical muscle-biology research.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Human data are limited to small early studies of gene-therapy constructs, not the isolated protein.

Scientific References

Documentation

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.